You searched for "disease"
Children with ‘lazy eye’ are at increased risk of serious disease in adulthood
Adults who had amblyopia (‘lazy eye’) in childhood are more likely to experience hypertension, obesity, and metabolic syndrome in adulthood, as well as an increased risk of heart attack, finds a new study led by UCL researchers.Moorfields: Pregnancy considerations in women with eye disease: a day of obstetrics for ophthalmologists
10 March 2025
Ophthalmic conditions are common in women of childbearing age, and treatments for these are evolving at a fast pace. When these women become pregnant, a common source of anxiety is both the potential continuation of these medications, as well as...
Eye scans detect signs of Parkinson’s disease up to seven years before diagnosis
22 August 2023
|
moorfields, Parkinson's disease, Siegfried Wagner, Pearse Keane, UCL Institute of Ophthalmology, early detection
A team led by Siegfried Wagner and Pearse Keane of Moorfields Eye Hospital and UCL Institute of Ophthalmology (and spanning UCL institutions) has identified markers that indicate the presence of Parkinson’s disease in patients on average seven years before clinical presentation.
A Lifestyle Epidemic: Ocular Surface Disease
6 May 2023
-7 May 2023
The Tear Film & Ocular Surface Society (TFOS), a world leader in eye health research and education, has just completed its recent global Workshop, entitled “A Lifestyle Epidemic: Ocular Surface Disease.” These 8 presentations will be available to watch at any time during these 2 days. More details upon registration.
UCL Institute of Ophthalmology and Moorfields Eye Hospital: Masterclass in External Eye Disease
1 April 2024
-30 June 2024
External Eye Diseases is a subspeciality of Ophthalmology that deals with conditions of the front surface of the eye (anterior segment). In this course, you will learn about the presentation, diagnosis, and contemporary management of external eye pathologies.
Available from Monday 15 January.
AI in anterior segment disease - what you need to know! @ 100% Ophthalmology
25 February 2024
@11:30 – 12:30
Everything you need to understand before you start to consider using AI in your practice with a focus on anterior segment disease!
Cybersight: Clinical Technology & Surgical Techniques in the Evolving Management of Corneal Diseases
15 November 2024
The current state of the art in the diagnosis and treatment of corneal diseases depends on imaging techniques to visualize the morphology, 3D structure, and optical quality of the cornea. Improvements in imaging allow for increasingly individualized treatment of corneal...
Real-world experience of using ciclosporin-A 0.1% in the management of ocular surface inflammatory diseases
This is a retrospective study of patients with ocular surface inflammatory diseases (OSIDs) treated with IKERVIS in a single centre between 2016 to 2019 with at least six months follow-up. Clinical outcome was defined as successful (resolved or stable disease),...World-first artificial intelligence foundation model for eye care to supercharge global efforts to prevent blindness
22 September 2023
|
oculomics, AI, moorfields, big data, RETFound, ChatGPT, UCL, artificial intelligence
Researchers at Moorfields Eye Hospital and UCL Institute of Ophthalmology (IoO) have developed an artificial intelligence (AI) system that has the potential to not only identify sight-threatening eye diseases but also predict general health, including heart attacks, stroke and Parkinson’s disease.
Burden of caregiving for children with eye diseases
This review was conducted to examine the existent literature and characterise the psychological impact of caregiving for children with various eye diseases. The factors associated with the burden of caregiving were discussed in the context of each eye disease identified....Moorfields: The 2025 macula course
2 June 2025
-5 June 2025
The 2025 Macula course will take place from 2nd - 5th June 2025. Bookings are now open. Retinal diseases are a major cause of blindness. Diagnostic investigations, understanding of disease mechanisms, new therapies, and the evidence base, have all evolved...